DNA Typing of HLA-DR/DQ Alleles in Taiwan Chinese With Rheumatic Heart Disease

This study has been completed.

Sponsored by:	China Medical University Hospital
Information provided by:	China Medical University Hospital
ClinicalTrials.gov Identifier:	NCT00264524

Purpose

The current study was designed to determine whether the HLA-DRB1, DQA1, DQB1 alleles are associated with the risk and the pattern of valve damage of RHD.

Condition	Intervention
Rheumatic Heart Disease	Procedure: venipuncture to withdraw patient's blood

MedlinePlus related topics: Heart Diseases

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Diagnostic, Non-Randomized, Open Label

Further study details as provided by China Medical University Hospital:

Study Start Date:	January 2004
Estimated Study Completion Date:	July 2005

Eligibility

Criteria

Inclusion Criteria:

1.Patients with Rheumatic mitral stenosis 2.Chinese Han ethnicity

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00264524

Locations

Taiwan
Division of cardiology, China Medical University Hospital
Taichung, Taiwan, 403

Sponsors and Collaborators

China Medical University Hospital

Investigators

Principal Investigator:

Hsiang-Tai Chou, MD, PhD

China Medical University Hospital

More Information

Study ID Numbers:	CMU93-M-34
Study First Received:	December 12, 2005
Last Updated:	December 12, 2005
ClinicalTrials.gov Identifier:	NCT00264524
Health Authority:	Taiwan:Ministry of Health

Keywords provided by China Medical University Hospital:

Rheumatic heart disease, HLA, Genetics, Taiwan

Study placed in the following topic categories:

Bacterial Infections
Fever
Gram-Positive Bacterial Infections
Heart Diseases
Rheumatic Heart Disease
Musculoskeletal Diseases

Streptococcal Infections
Connective Tissue Diseases
Acute articular rheumatism
Rheumatic Fever
Rheumatic Diseases

Additional relevant MeSH terms:

Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009